Guangpu Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guangpu Fan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Yu Chen
Peking University People's Hospital
2 shared publications- Yu Chen
Cardiac Surgery Department, Peking University People’s Hospital, Beijing, China
2 shared publications Chen Chen
Peking University People's Hospital
1 shared publication- Chen Chen
Department of Thoracic Surgery, the Second Xiangya Hospital of Central South University, Changsha, People’s Republic of China
1 shared publication - Cheng Guo
Allianz Technology, Allianz, Munich, Germany
1 shared publication - Chenyu Li
Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication
Latest Publications
- Open Access
- 30 January 2024
- Published by Wiley
Surgeons’ preference for off pump or on pump coronary artery bypass grafting surgery: different level, different strategy?
Background: Surgeon‘s preference is an important factor in clinical strategy for off pump (OPCAB) or on pump (ONCAB) coronary artery bypass graft (CABG) surgery. This study analyzed the surgeons’ understanding and the propensity for both techniques. Methods: A self-reported questionnaire survey was performed. Two sections were included :(1) Q1 questionnaire: to investigate the surgeon’s opinion on the indications of OPCAB and ONCAB; (2) Q2 questionnaire: to investigate the surgeons’ choice of OPCAB or ONCAB in different clinical situations. Results: The questionnaires were sent to 169 surgeons. In Q1 questionnaire, 71.2% surgeons surveyed chose the option which represents that the degree of overlap between the indications of OPCAB and ONCAB would be greater than 70%. 55.1% surgeons believed that OPCAB had a wider scope of indications than ONCAB, while 35.3% surgeons believed that ONCAB had more extensive indications than OPCAB. In Q2 questionnaire, more than 70% of surgeons surveyed chose OPCAB for patients at high risk of stroke, with renal dysfunction, pulmonary dysfunction, malignancy, clotting and coagulation disorders or octogenarian patients, while more than 57.5% of surgeons surveyed chose ONCAB with the conditions of poor target vessels, ventricular enlargement and dysfunction. 87.5% surgeons made the choice of ONCAB for novice surgeons. Conclusion: Most surgeons surveyed agreed that OPCAB and ONCAB are suitable for most of the patients. Surgeons are more willing to choose ONCAB when facing complicated heart conditions, while choose OPCAB in the presence of more serious concomitant diseases.
- 30 January 2024
- Published by Wiley
Open AccessSurgeons’ preference for off pump or on pump coronary artery bypass grafting surgery: different level, different strategy?
Background: Surgeon‘s preference is an important factor in clinical strategy for off pump (OPCAB) or on pump (ONCAB) coronary artery bypass graft (CABG) surgery. This study analyzed the surgeons’ understanding and the propensity for both techniques. Methods: A self-reported questionnaire survey was performed. Two sections were included :(1) Q1 questionnaire: to investigate the surgeon’s opinion on the indications of OPCAB and ONCAB; (2) Q2 questionnaire: to investigate the surgeons’ choice of OPCAB or ONCAB in different clinical situations. Results: The questionnaires were sent to 169 surgeons. In Q1 questionnaire, 71.2% surgeons surveyed chose the option which represents that the degree of overlap between the indications of OPCAB and ONCAB would be greater than 70%. 55.1% surgeons believed that OPCAB had a wider scope of indications than ONCAB, while 35.3% surgeons believed that ONCAB had more extensive indications than OPCAB. In Q2 questionnaire, more than 70% of surgeons surveyed chose OPCAB for patients at high risk of stroke, with renal dysfunction, pulmonary dysfunction, malignancy, clotting and coagulation disorders or octogenarian patients, while more than 57.5% of surgeons surveyed chose ONCAB with the conditions of poor target vessels, ventricular enlargement and dysfunction. 87.5% surgeons made the choice of ONCAB for novice surgeons. Conclusion: Most surgeons surveyed agreed that OPCAB and ONCAB are suitable for most of the patients. Surgeons are more willing to choose ONCAB when facing complicated heart conditions, while choose OPCAB in the presence of more serious concomitant diseases.
- Open Access
- 23 March 2023
- Published by JMIR Publications Inc. in Interactive Journal of Medical Research
- Vol. 12 (1) , e45898
Prediction of Male Coronary Artery Bypass Grafting Outcomes Using Body Surface Area Weighted Left Ventricular End-diastolic Diameter: Multicenter Retrospective Cohort Study
Background: The presence of a high left ventricular end-diastolic diameter (LVEDD) has been linked to a less favorable outcome in patients undergoing coronary artery bypass grafting (CABG) procedures. However, by taking into consideration the reference of left ventricular size and volume measurements relative to the patient's body surface area (BSA), it has been suggested that the accuracy of the predicting outcomes may be improved. Objective: We propose that BSA weighted LVEDD (bLVEDD) is a more accurate predictor of outcomes in patients undergoing CABG compared to simply using LVEDD alone. Methods: This study was a comprehensive retrospective cohort study that was conducted across multiple medical centers. The inclusion criteria for this study were patients who were admitted for treatment between October 2016 and May 2021. Only elective surgery patients were included in the study, while those undergoing emergency surgery were not considered. All participants in the study received standard care, and their clinical data were collected through the institutional registry in accordance with the guidelines set forth by the Society of Thoracic Surgeons National Adult Cardiac Database. bLVEDD was defined as LVEDD divided by BSA. The primary outcome was in-hospital all-cause mortality (30 days), and the secondary outcomes were postoperative severe adverse events, including use of extracorporeal membrane oxygenation, multiorgan failure, use of intra-aortic balloon pump, postoperative stroke, and postoperative myocardial infarction. Results: In total, 9474 patients from 5 centers under the Chinese Cardiac Surgery Registry were eligible for analysis. We found that a high LVEDD was a negative factor for male patients’ mortality (odds ratio 1.44, P<.001) and secondary outcomes. For female patients, LVEDD was associated with secondary outcomes but did not reach statistical differences for morality. bLVEDD showed a strong association with postsurgery mortality (odds ratio 2.70, P<.001), and secondary outcomes changed in parallel with bLVEDD in male patients. However, bLVEDD did not reach statistical differences when fitting either mortality or severer outcomes in female patients. In male patients, the categorical bLVEDD showed high power to predict mortality (area under the curve [AUC] 0.71, P<.001) while BSA (AUC 0.62) and LVEDD (AUC 0.64) both contributed to the risk of mortality but were not as significant as bLVEDD (P<.001). Conclusions: bLVEDD is an important predictor for male mortality in CABG, removing the bias of BSA and showing a strong capability to accurately predict mortality outcomes. Trial Registration: ClinicalTrials.gov NCT02400125; https://clinicaltrials.gov/ct2/show/NCT02400125
- 23 March 2023
- Published by JMIR Publications Inc. in Interactive Journal of Medical Research
- Vol. 12 (1) , e45898
Open AccessPrediction of Male Coronary Artery Bypass Grafting Outcomes Using Body Surface Area Weighted Left Ventricular End-diastolic Diameter: Multicenter Retrospective Cohort Study
Background: The presence of a high left ventricular end-diastolic diameter (LVEDD) has been linked to a less favorable outcome in patients undergoing coronary artery bypass grafting (CABG) procedures. However, by taking into consideration the reference of left ventricular size and volume measurements relative to the patient's body surface area (BSA), it has been suggested that the accuracy of the predicting outcomes may be improved. Objective: We propose that BSA weighted LVEDD (bLVEDD) is a more accurate predictor of outcomes in patients undergoing CABG compared to simply using LVEDD alone. Methods: This study was a comprehensive retrospective cohort study that was conducted across multiple medical centers. The inclusion criteria for this study were patients who were admitted for treatment between October 2016 and May 2021. Only elective surgery patients were included in the study, while those undergoing emergency surgery were not considered. All participants in the study received standard care, and their clinical data were collected through the institutional registry in accordance with the guidelines set forth by the Society of Thoracic Surgeons National Adult Cardiac Database. bLVEDD was defined as LVEDD divided by BSA. The primary outcome was in-hospital all-cause mortality (30 days), and the secondary outcomes were postoperative severe adverse events, including use of extracorporeal membrane oxygenation, multiorgan failure, use of intra-aortic balloon pump, postoperative stroke, and postoperative myocardial infarction. Results: In total, 9474 patients from 5 centers under the Chinese Cardiac Surgery Registry were eligible for analysis. We found that a high LVEDD was a negative factor for male patients’ mortality (odds ratio 1.44, P<.001) and secondary outcomes. For female patients, LVEDD was associated with secondary outcomes but did not reach statistical differences for morality. bLVEDD showed a strong association with postsurgery mortality (odds ratio 2.70, P<.001), and secondary outcomes changed in parallel with bLVEDD in male patients. However, bLVEDD did not reach statistical differences when fitting either mortality or severer outcomes in female patients. In male patients, the categorical bLVEDD showed high power to predict mortality (area under the curve [AUC] 0.71, P<.001) while BSA (AUC 0.62) and LVEDD (AUC 0.64) both contributed to the risk of mortality but were not as significant as bLVEDD (P<.001). Conclusions: bLVEDD is an important predictor for male mortality in CABG, removing the bias of BSA and showing a strong capability to accurately predict mortality outcomes. Trial Registration: ClinicalTrials.gov NCT02400125; https://clinicaltrials.gov/ct2/show/NCT02400125
- Open Access
- 11 May 2021
- Published by IMR Press in The Heart Surgery Forum
- Vol. 24 (3) , E422-E426
Surgeons’ Preference for Off-Pump or On-Pump Coronary Artery Bypass Grafting Surgery
Background: Surgeon’s preference is an important factor in clinical strategy for off-pump (OPCAB) or on-pump (ONCAB) coronary artery bypass graft (CABG) surgery. This study analyzed surgeons’ understanding of and propensity for both techniques. Methods: A survey was performed by self-reported questionnaire. Two sections were included: Q1 questionnaire investigated each surgeon’s opinion on the indications of OPCAB and ONCAB; and Q2 questionnaire investigated each surgeon’s choice of OPCAB or ONCAB in different clinical situations. Results: The questionnaires were sent to 169 surgeons. In Q1, 71.2% of surgeons indicated that the degree of overlap between the indications of OPCAB and ONCAB is >70%; 55.1% believed that OPCAB had a wider scope of indications than ONCAB, and 35.3% believed that ONCAB had a wider scope of indications than OPCAB. In Q2, >70% of surgeons who responded chose OPCAB for patients with the following characteristics: high risk of stroke, renal dysfunction, pulmonary dysfunction, malignancy, clotting and coagulation disorders, or age ≥80 years. More than 57.5% of surgeons chose ONCAB for patients with poor target vessels or ventricular enlargement and dysfunction. For novice surgeons, 87.5% of surgeons chose ONCAB. Conclusion: Most surgeons surveyed agreed that OPCAB and ONCAB are suitable for most patients; however, surgeons’ preference for ONCAB or OPCAB varied. Surgeons are more willing to choose ONCAB in the presence of complicated heart conditions and OPCAB in the presence of serious concomitant diseases.
- 11 May 2021
- Published by IMR Press in The Heart Surgery Forum
- Vol. 24 (3) , E422-E426
Open AccessSurgeons’ Preference for Off-Pump or On-Pump Coronary Artery Bypass Grafting Surgery
Background: Surgeon’s preference is an important factor in clinical strategy for off-pump (OPCAB) or on-pump (ONCAB) coronary artery bypass graft (CABG) surgery. This study analyzed surgeons’ understanding of and propensity for both techniques. Methods: A survey was performed by self-reported questionnaire. Two sections were included: Q1 questionnaire investigated each surgeon’s opinion on the indications of OPCAB and ONCAB; and Q2 questionnaire investigated each surgeon’s choice of OPCAB or ONCAB in different clinical situations. Results: The questionnaires were sent to 169 surgeons. In Q1, 71.2% of surgeons indicated that the degree of overlap between the indications of OPCAB and ONCAB is >70%; 55.1% believed that OPCAB had a wider scope of indications than ONCAB, and 35.3% believed that ONCAB had a wider scope of indications than OPCAB. In Q2, >70% of surgeons who responded chose OPCAB for patients with the following characteristics: high risk of stroke, renal dysfunction, pulmonary dysfunction, malignancy, clotting and coagulation disorders, or age ≥80 years. More than 57.5% of surgeons chose ONCAB for patients with poor target vessels or ventricular enlargement and dysfunction. For novice surgeons, 87.5% of surgeons chose ONCAB. Conclusion: Most surgeons surveyed agreed that OPCAB and ONCAB are suitable for most patients; however, surgeons’ preference for ONCAB or OPCAB varied. Surgeons are more willing to choose ONCAB in the presence of complicated heart conditions and OPCAB in the presence of serious concomitant diseases.
- Open Access
- 6 December 2020
- Published by Wiley
Surgical resection of a giant cardiac hemangioma encroached upon the right coronary artery: A case report
Cardiac hemangioma is relatively rare for primary cardiac tumors. The diagnose is mainly based on surgical resection and biopsy, imaging examinations only provide limited diagnostic clues. For those giant cardiac hemangiomas, which may raise a risk of rupture, need thoroughly surgical removal. However, meticulous follow-up is required due to its possibility of recurrence.
- 6 December 2020
- Published by Wiley
Open AccessSurgical resection of a giant cardiac hemangioma encroached upon the right coronary artery: A case report
Cardiac hemangioma is relatively rare for primary cardiac tumors. The diagnose is mainly based on surgical resection and biopsy, imaging examinations only provide limited diagnostic clues. For those giant cardiac hemangiomas, which may raise a risk of rupture, need thoroughly surgical removal. However, meticulous follow-up is required due to its possibility of recurrence.